CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells
In this webinar, Dr. Mark DeWitt, Postdoctoral Fellow at University of California, discuss the use of gene editing techniques for hematopoietic stem and progenitor cells (HSPCs).
Publish Date:
June 26, 2018
Related Multimedia
-
New Tools for the Ex Vivo Expansion of Human Hematopoietic Stem and Progenitor Cells
Publish Date: March 09, 2015 -
Targeting Self-Renewal Function in Normal Hematopoietic and Leukemic Stem Cells
Publish Date: February 03, 2017 -
Using CRISPR/Cas9 to Model Stem Cell Organization and Dynamics
Publish Date: August 25, 2017
Explore Our Products
-
cGMP medium, for culture and expansion of human hematopoietic cells -
StemSpan™ Erythroid Expansion Supplement (100X)
Serum-free culture supplement for expansion of human erythroid cells -
Enhanced green fluorescent protein (eGFP)-tagged Cas9 nuclease for the generation of double-strand breaks in CRISPR-Cas9 genome editing -
Serum-free medium for culture and expansion of hematopoietic cells
